These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 34964599)

  • 81. A Biosensor Assay Based on Coiled-Coil-Mediated Human ACE2 Receptor Capture for the Analysis of Its Interactions with the SARS-CoV-2 Receptor Binding Domain.
    Forest-Nault C; Koyuturk I; Gaudreault J; Pelletier A; L'Abbé D; Cass B; Bisson L; Burlacu A; Delafosse L; Stuible M; Henry O; De Crescenzo G; Durocher Y
    Methods Mol Biol; 2024; 2762():89-105. PubMed ID: 38315361
    [TBL] [Abstract][Full Text] [Related]  

  • 82. SARS-CoV-2S-Protein-Ace2 Binding Analysis Using Surface Plasmon Resonance.
    Baardsnes J; Paul-Roc B
    Methods Mol Biol; 2024; 2762():71-87. PubMed ID: 38315360
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.
    Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H
    Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Advanced Analysis of Biosensor Data for SARS-CoV-2 RBD and ACE2 Interactions.
    Forssén P; Samuelsson J; Lacki K; Fornstedt T
    Anal Chem; 2020 Sep; 92(17):11520-11524. PubMed ID: 32786452
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
    Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
    Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein.
    Verma S; Patil VM; Gupta MK
    Drug Discov Today; 2022 Oct; 27(10):103312. PubMed ID: 35787481
    [TBL] [Abstract][Full Text] [Related]  

  • 87. SARS-CoV-2, ACE2 expression, and systemic organ invasion.
    Ashraf UM; Abokor AA; Edwards JM; Waigi EW; Royfman RS; Hasan SA; Smedlund KB; Hardy AMG; Chakravarti R; Koch LG
    Physiol Genomics; 2021 Feb; 53(2):51-60. PubMed ID: 33275540
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19.
    Ma LL; Liu HM; Liu XM; Yuan XY; Xu C; Wang F; Lin JZ; Xu RC; Zhang DK
    Eur J Med Chem; 2021 Dec; 226():113857. PubMed ID: 34628234
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Biosensor-Enabled Deconvolution of the Avidity-Induced Affinity Enhancement for the SARS-CoV-2 Spike Protein and ACE2 Interaction.
    Gutgsell AR; Gunnarsson A; Forssén P; Gordon E; Fornstedt T; Geschwindner S
    Anal Chem; 2022 Jan; 94(2):1187-1194. PubMed ID: 34964599
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Unraveling the Dynamics of SARS-CoV-2 Mutations: Insights from Surface Plasmon Resonance Biosensor Kinetics.
    Nurrohman DT; Chiu NF
    Biosensors (Basel); 2024 Feb; 14(2):. PubMed ID: 38392018
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective.
    Borkotoky S; Dey D; Hazarika Z
    Mol Biol Rep; 2023 Mar; 50(3):2713-2721. PubMed ID: 36562937
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2).
    Xiang Y; Wang M; Chen H; Chen L
    Biochem Pharmacol; 2021 Oct; 192():114724. PubMed ID: 34371003
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.